Role of inhaled human insulin in the management of Type 1 and 2 diabetes

Authors: Briscoe, Vanessa J; Davis, Stephen N

Source: Expert Review of Endocrinology and Metabolism, Volume 1, Number 4, July 2006 , pp. 479-488(10)

Buy & download fulltext article:

Price: $73.00 plus tax (Refund Policy)

Abstract:

Inhaled human insulin (Exubera^®) has been approved by the FDA and other regulatory bodies for treatment in Type 1 and 2 diabetes in the USA. It is the first alternative to injectable insulin since the discovery of the insulin compound to treat diabetes. This article will review results of recent clinical studies that support the therapeutic efficacy and safety of inhalable insulin for use in patients with diabetes. The pharmacological profile of inhaled insulin with particular reference to inhaled human insulin and the potential to influence diabetes care is also discussed.

Keywords: diabetes Type 1; diabetes Type 2; exubera; inhaled insulin

Document Type: Research article

DOI: http://dx.doi.org/10.1586/17446651.1.4.479

Publication date: 2006-07-01

More about this publication?

Expert Review of Endocrinology & Metabolism provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology
Editorial Board
Information for Authors
Submit a Paper
Subscribe to this Title
Information for Advertisers
Terms & Conditions
Information for Librarians
Free Trials
ingentaconnect is not responsible for the content or availability of external websites